Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvastatin in Acute Coronary Syndrome
NCT00171275Phase 4Completed
- Sponsor
- Novartis
- Start
- Nov 2003
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute coronary syndrome (ACS) comparing Fluvastatin Arm with Placebo Arm (2 arms). Primary endpoint: Change from baseline in circulating markers of inflammation at 52 weeks. Started Nov 2003; status: completed.
02
Drugs
fluvastatin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00171275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171275.